Abstract:Diabetes mellitus is a chronic endocrine disease, affecting more than 400 million people around the world. Patients with poorly controlled blood glucose levels are liable to suffer from life-threatening complications, such as cardiovascular, neuropathy, retinopathy and even premature death. Today, subcutaneous parenteral is still the most common route for insulin therapy. Oral insulin administration is favourable and convenient to the patients. In contrast to injection route, oral insulin delivery mimics the physiological pathway of endogenous insulin secretion. However, oral insulin has poor bioavailability (less than 2%) due to the harsh physiological environment through the gastrointestinal tract (GIT). Over the last few decades, many attempts have been made to achieve an effective oral insulin formulation with high bioavailability using insulin encapsulation into nanoparticles as advanced technology. Various natural polymers have been employed to fabricate nanoparticles as a delivery vehicle for insulin oral administration. Chitosan, a natural polymer, is extensively studied due to the attractive properties, such as biodegradability, biocompatibility, bioactivity, nontoxicity and polycationic nature. Numerous studies were conducted to evaluate chitosan and chitosan derivatives-based nanoparticles capabilities for oral insulin delivery. This review highlights strategies that have been applied in the recent five years to fabricate chitosan/chitosan derivatives-based nanoparticles for oral insulin delivery. A summary of the barriers hurdle insulin absorption rendering its low bioavailability such as physical, chemical and enzymatic barriers are highlighted with an emphasis on the most common methods of chitosan nanoparticles preparation. Nanocarriers are able to improve the absorption of insulin through GIT, deliver insulin to the blood circulation and lower blood glucose levels. In spite of some drawbacks encountered in this technology, chitosan and chitosan derivatives-based nanoparticles are greatly promising entities for oral insulin delivery.

The crossroad of nanovesicles and oral delivery of insulin

Oral Insulin Delivery: A Review On Recent Advancements And Novel Strategies.

Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Recent advances in oral insulin delivery technologies

Advancements in Oral Drug Delivery of Insulin: A Review

Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes

Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Oral Delivery of Insulin by Barbed Microneedles Actuated by Intestinal Peristalsis

A Novel Approach to Insulin Delivery via Oral Route: Milk Fat Globule Membrane Derived Liposomes as a Delivery Vehicle

Various non-injectable delivery systems for the treatment of diabetes mellitus

Synthesis of a novel structure for the oral delivery of insulin and the study of its effect on diabetic rats

A comprehensive review of oral chitosan drug delivery systems: Applications for oral insulin delivery

Fabrication and evaluation of nanoemulsion based insulin loaded microneedles for transdermal drug delivery

Microneedle-based insulin transdermal delivery system: current status and translation challenges

Materials and structure of polysaccharide-based delivery carriers for oral insulin: A review

Crosslinked zwitterionic microcapsules to overcome gastrointestinal barriers for oral insulin delivery

Engineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes